Provectus News PV-10 in Metastatic Melanoma: R
Post# of 22756
Posted On: 11/03/2014 2:30:14 PM
Provectus News
PV-10 in Metastatic Melanoma: Rapid Responses Led Phase 3
Monday November 3, 2014
In an article appearing on Medscape, author Walter Alexander reports that PV-10 injected directly into skin lesions, has shown rapid complete responses in a high proportion of melanoma patients in early clinical trials and discusses phase 3 study plans.
The article may be viewed on the Medascape website at:
PV-10 in Metastatic Melanoma: Rapid Responses Led Phase 3.
(A free registration is required to view this article.)
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients In Early Trials
Monday November 3, 2014
An article appearing on ASCO Cancer in the News daily digest reports on data recently published in the Annals of Oncology showing that intralesional PV-10 leads to rapid complete responses in a high proportion of patients in a phase 2 trial.
The article may be viewed on the ASCO Cancer in the News website at:
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients In Early Trials.
PV-10 in Metastatic Melanoma: Rapid Responses Led Phase 3
Monday November 3, 2014
In an article appearing on Medscape, author Walter Alexander reports that PV-10 injected directly into skin lesions, has shown rapid complete responses in a high proportion of melanoma patients in early clinical trials and discusses phase 3 study plans.
The article may be viewed on the Medascape website at:
PV-10 in Metastatic Melanoma: Rapid Responses Led Phase 3.
(A free registration is required to view this article.)
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients In Early Trials
Monday November 3, 2014
An article appearing on ASCO Cancer in the News daily digest reports on data recently published in the Annals of Oncology showing that intralesional PV-10 leads to rapid complete responses in a high proportion of patients in a phase 2 trial.
The article may be viewed on the ASCO Cancer in the News website at:
Investigational Agent For Metastatic Melanoma Shows Rapid Complete Responses In High Proportion Of Patients In Early Trials.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼